Quantcast
Home » News
Home » News

NIH, drugmakers, foundations partner to find meds

Published February 4, 2014 9:07 am
This is an archived article that was published on sltrib.com in 2014, and information in the article may be outdated. It is provided only for personal research purposes and may not be reprinted.

Washington, D.C. • The U.S. National Institutes of Health will collaborate with numerous biopharmaceutical companies and disease foundations on an unusual project to find and bring new medicines to patients faster.

The Accelerating Medicines Partnership, just announced, will focus on the early part of drug research — identifying biological targets present in a disease, such as abnormal genes or particular proteins.

The partnership will aim to develop new diagnostic tests and therapies focused on those targets, but more quickly and at a lower cost than today's typical drug development.



The new collaboration will start with pilot projects in three disease areas: Alzheimer's, type 2 diabetes and autoimmune disorders such as rheumatoid arthritis and lupus.

 

 

 

USER COMMENTS
Reader comments on sltrib.com are the opinions of the writer, not The Salt Lake Tribune. We will delete comments containing obscenities, personal attacks and inappropriate or offensive remarks. Flagrant or repeat violators will be banned. If you see an objectionable comment, please alert us by clicking the arrow on the upper right side of the comment and selecting "Flag comment as inappropriate". If you've recently registered with Disqus or aren't seeing your comments immediately, you may need to verify your email address. To do so, visit disqus.com/account.
See more about comments here.
comments powered by Disqus